| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.06e-04 | 42 | 117 | 4 | GO:0098918 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 7.09e-07 | 4 | 117 | 3 | GO:0098928 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.72e-04 | 523 | 117 | 11 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.26e-04 | 451 | 117 | 10 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.52e-04 | 477 | 117 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.33e-04 | 503 | 117 | 10 | GO:0099572 | |
| HumanPheno | Conductive hearing impairment | GDF5 TCOF1 NSD2 APC2 DDR2 SRCAP KMT2D RECQL4 UFD1 DLST SPEN SDHA RAD21 | 9.06e-06 | 373 | 44 | 13 | HP:0000405 |
| HumanPheno | Abnormal synovial membrane morphology | GDF5 NSD2 APC2 DDR2 AFF3 SRCAP SH3PXD2B KMT2D RECQL4 ELN MMP2 MBD5 SPEN PRG4 RAD21 | 1.03e-05 | 503 | 44 | 15 | HP:0005262 |
| HumanPheno | Functional abnormality of the middle ear | GDF5 TCOF1 NSD2 APC2 DDR2 SRCAP KMT2D RECQL4 UFD1 DLST SPEN SDHA RAD21 | 1.32e-05 | 386 | 44 | 13 | HP:0011452 |
| HumanPheno | Abnormal hip joint morphology | GDF5 NSD2 APC2 DDR2 AFF3 SRCAP SH3PXD2B KMT2D RECQL4 ELN MMP2 MBD5 SPEN RAD21 | 3.66e-05 | 490 | 44 | 14 | HP:0001384 |
| HumanPheno | Bulbous nose | 4.13e-05 | 201 | 44 | 9 | HP:0000414 | |
| HumanPheno | Abnormality of the metacarpal bones | 1.11e-04 | 228 | 44 | 9 | HP:0001163 | |
| HumanPheno | Abnormal metacarpal morphology | 1.11e-04 | 228 | 44 | 9 | HP:0005916 | |
| HumanPheno | Neoplasm of the middle ear | 1.25e-04 | 12 | 44 | 3 | HP:0100799 | |
| HumanPheno | Cholesteatoma | 1.25e-04 | 12 | 44 | 3 | HP:0009797 | |
| HumanPheno | Downturned corners of mouth | 1.34e-04 | 182 | 44 | 8 | HP:0002714 | |
| HumanPheno | Abnormality of dental eruption | 1.64e-04 | 240 | 44 | 9 | HP:0006292 | |
| HumanPheno | Hip dysplasia | 2.04e-04 | 247 | 44 | 9 | HP:0001385 | |
| HumanPheno | Myxomatous mitral valve degeneration | 2.18e-04 | 3 | 44 | 2 | HP:0004764 | |
| HumanPheno | Abnormal hip bone morphology | GDF5 NSD2 APC2 DDR2 AFF3 SRCAP SH3PXD2B KMT2D RECQL4 ELN MMP2 MBD5 SPEN PRG4 RAD21 | 2.24e-04 | 653 | 44 | 15 | HP:0003272 |
| HumanPheno | Renal hypoplasia | 2.26e-04 | 147 | 44 | 7 | HP:0000089 | |
| HumanPheno | Hemangioma | 2.67e-04 | 151 | 44 | 7 | HP:0001028 | |
| HumanPheno | Vascular neoplasm | 3.13e-04 | 155 | 44 | 7 | HP:0100742 | |
| HumanPheno | Abnormal nasal tip morphology | AFF3 INTS1 SRCAP SH3PXD2B KMT2D UFD1 ELN MMP2 MBD5 SPEN RAD21 | 3.20e-04 | 386 | 44 | 11 | HP:0000436 |
| HumanPheno | Narrow palpebral fissure | 3.25e-04 | 71 | 44 | 5 | HP:0045025 | |
| HumanPheno | Conotruncal defect | 3.36e-04 | 264 | 44 | 9 | HP:0001710 | |
| Domain | PDZ | 4.32e-06 | 151 | 115 | 8 | PS50106 | |
| Domain | DUF3669_Znf | 4.49e-06 | 6 | 115 | 3 | IPR022137 | |
| Domain | DUF3669 | 4.49e-06 | 6 | 115 | 3 | PF12417 | |
| Domain | PDZ | 4.53e-06 | 152 | 115 | 8 | IPR001478 | |
| Domain | PDZ | 2.67e-05 | 141 | 115 | 7 | PF00595 | |
| Domain | PDZ | 3.65e-05 | 148 | 115 | 7 | SM00228 | |
| Domain | Znf_piccolo | 3.76e-05 | 2 | 115 | 2 | IPR008899 | |
| Domain | zf-piccolo | 3.76e-05 | 2 | 115 | 2 | PF05715 | |
| Domain | - | 3.98e-05 | 150 | 115 | 7 | 2.30.42.10 | |
| Domain | SH3 | 5.76e-05 | 216 | 115 | 8 | SM00326 | |
| Domain | SH3 | 5.76e-05 | 216 | 115 | 8 | PS50002 | |
| Domain | SH3_domain | 6.55e-05 | 220 | 115 | 8 | IPR001452 | |
| Domain | Znf_RING/FYVE/PHD | 5.44e-04 | 459 | 115 | 10 | IPR013083 | |
| Domain | Dynamin_central | 5.55e-04 | 6 | 115 | 2 | IPR000375 | |
| Domain | GED | 5.55e-04 | 6 | 115 | 2 | SM00302 | |
| Domain | Dynamin_M | 5.55e-04 | 6 | 115 | 2 | PF01031 | |
| Domain | GED_dom | 5.55e-04 | 6 | 115 | 2 | IPR020850 | |
| Domain | GED | 5.55e-04 | 6 | 115 | 2 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 5.55e-04 | 6 | 115 | 2 | IPR019762 | |
| Domain | GED | 5.55e-04 | 6 | 115 | 2 | PF02212 | |
| Domain | GED | 5.55e-04 | 6 | 115 | 2 | IPR003130 | |
| Domain | G_DYNAMIN_1 | 7.74e-04 | 7 | 115 | 2 | PS00410 | |
| Domain | DYNc | 7.74e-04 | 7 | 115 | 2 | SM00053 | |
| Domain | ZU5 | 1.32e-03 | 9 | 115 | 2 | SM00218 | |
| Domain | Rap_GAP | 1.64e-03 | 10 | 115 | 2 | PF02145 | |
| Domain | ZU5 | 1.64e-03 | 10 | 115 | 2 | PS51145 | |
| Domain | - | 1.84e-03 | 449 | 115 | 9 | 3.30.40.10 | |
| Domain | SH3_2 | 1.96e-03 | 86 | 115 | 4 | PF07653 | |
| Domain | SH3_2 | 1.96e-03 | 86 | 115 | 4 | IPR011511 | |
| Domain | Rap_GAP_dom | 1.99e-03 | 11 | 115 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.99e-03 | 11 | 115 | 2 | PS50085 | |
| Domain | Znf_FYVE_PHD | 2.16e-03 | 147 | 115 | 5 | IPR011011 | |
| Domain | ZU5 | 2.38e-03 | 12 | 115 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.38e-03 | 12 | 115 | 2 | IPR000906 | |
| Domain | G_DYNAMIN_dom | 3.26e-03 | 14 | 115 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 3.26e-03 | 14 | 115 | 2 | PS51718 | |
| Domain | WH2 | 3.26e-03 | 14 | 115 | 2 | SM00246 | |
| Domain | SH3_1 | 3.47e-03 | 164 | 115 | 5 | PF00018 | |
| Domain | Dynamin_GTPase | 3.74e-03 | 15 | 115 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 3.74e-03 | 15 | 115 | 2 | IPR022812 | |
| Domain | Dynamin_N | 3.74e-03 | 15 | 115 | 2 | PF00350 | |
| Domain | Post-SET_dom | 4.26e-03 | 16 | 115 | 2 | IPR003616 | |
| Domain | PostSET | 4.26e-03 | 16 | 115 | 2 | SM00508 | |
| Domain | WH2 | 4.26e-03 | 16 | 115 | 2 | PF02205 | |
| Domain | POST_SET | 4.26e-03 | 16 | 115 | 2 | PS50868 | |
| Domain | Hemopexin_CS | 4.81e-03 | 17 | 115 | 2 | IPR018486 | |
| Domain | TF_GTP-bd_dom | 6.00e-03 | 19 | 115 | 2 | IPR000795 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | COL4A5 REPS1 NSD2 INTS1 FBRSL1 CC2D1A TBC1D25 EDC4 SRCAP TEP1 ZBTB42 MPRIP SH3PXD2B SLC38A10 KMT2D CASKIN1 ZNF398 SIPA1L2 MBD5 SPEN ULK2 SDHA | 1.75e-11 | 1105 | 117 | 22 | 35748872 |
| Pubmed | ANK2 TCOF1 MAP6 ZNF618 APC2 NBEA EDC4 SIPA1 MPRIP NOSIP SH3PXD2B PTPRD TJP1 FARP1 CASKIN1 RAB3IP DNM3 DLG3 BSN DNM2 | 7.78e-11 | 963 | 117 | 20 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 REXO4 RPAP3 CC2D1A PDLIM5 GSPT1 MPRIP NOSIP PCGF6 SH3PXD2B TJP1 FARP1 MKI67 UQCRC2 SPEN DHX29 NNT | 3.71e-10 | 724 | 117 | 17 | 36232890 |
| Pubmed | REPS1 TCOF1 RPAP3 RPS3 PPP1R13B CC2D1A EDC4 SRCAP PDLIM5 MPRIP KIAA1671 SH3PXD2B KMT2D TJP1 SPEN | 5.61e-10 | 549 | 117 | 15 | 38280479 | |
| Pubmed | ZNF609 REXO4 BMS1 FBRSL1 KLF15 PPP1R13B CC2D1A RBM28 EDC4 GMEB2 SRCAP MPRIP NOSIP ZNF512B KIAA1671 PCGF6 KMT2D MKI67 IRF2BPL UQCRC2 SPEN RAD21 | 2.20e-09 | 1429 | 117 | 22 | 35140242 | |
| Pubmed | ANK2 MAP6 RPS3 PCLO KLC2 NBEA EDC4 SIPA1 PDLIM5 MPRIP TJP1 FARP1 CASKIN1 DLG3 DLST UQCRC2 BSN SIPA1L2 DHX29 KNG1 SDHA DNM2 | 2.26e-09 | 1431 | 117 | 22 | 37142655 | |
| Pubmed | REXO4 TCOF1 NSD2 INTS1 BMS1 RBM28 EDC4 TJP1 MKI67 UQCRC2 SPEN NNT SDHA DNM2 RAD21 | 5.85e-09 | 653 | 117 | 15 | 22586326 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | REPS1 ANK2 TCOF1 RPAP3 CC2D1A EDC4 SRCAP PDLIM5 MPRIP ZNF512B KIAA1671 TJP1 MKI67 SIPA1L2 DHX29 DNM2 RAD21 | 1.65e-08 | 934 | 117 | 17 | 33916271 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ATRN REXO4 ZNF618 PCLO INTS1 BMS1 FRS2 NBEA RBM28 KIAA1671 SLC38A10 RECQL4 MMP2 PRG4 SDHA | 2.85e-08 | 736 | 117 | 15 | 29676528 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | REXO4 TCOF1 MAP6 NSD2 RPS3 ZNF618 INTS1 BMS1 SRCAP ZNF512B TJP1 FARP1 DNM3 DLST UQCRC2 SIPA1L2 SPEN | 1.36e-07 | 1082 | 117 | 17 | 38697112 |
| Pubmed | LPCAT1 ZNF609 TCOF1 NSD2 ZNF618 NTPCR FBRSL1 ZNF362 SIPA1 SRCAP GPR108 TEP1 ZNF512B KIAA1671 TRIM66 CAPRIN2 SIPA1L2 | 2.10e-07 | 1116 | 117 | 17 | 31753913 | |
| Pubmed | TCOF1 SPRR3 RBM28 SIPA1 PDLIM5 GSPT1 MPRIP KIAA1671 RAB3IP MKI67 NNT DNM2 RAD21 | 2.38e-07 | 634 | 117 | 13 | 34591612 | |
| Pubmed | LPCAT1 NTPCR FBRSL1 TAB2 TBC1D25 NBEA NOSIP KMT2D LMOD1 DLST BSN SPEN DNM2 | 2.55e-07 | 638 | 117 | 13 | 31182584 | |
| Pubmed | ATRN REPS1 ANK2 TCOF1 APC2 NBEA HUNK SLC4A3 PDLIM5 MPRIP ZNF512B TRIM66 PTPRD TJP1 DNM3 DLST SDHA DNM2 | 3.05e-07 | 1285 | 117 | 18 | 35914814 | |
| Pubmed | ZNF609 RPAP3 NSD2 BMS1 PPP1R13B TAB2 NBEA ZNF362 ZNF512B KIAA1671 KMT2D PTPRD TJP1 FARP1 MKI67 UQCRC2 | 4.87e-07 | 1049 | 117 | 16 | 27880917 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPRR3 FRS2 KLC2 PPP1R13B CC2D1A PDLIM5 GSPT1 MPRIP KIAA1671 SH3PXD2B TJP1 DHX29 | 4.91e-07 | 565 | 117 | 12 | 25468996 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TCOF1 FBRSL1 KLC2 PPP1R13B TAB2 SRCAP MPRIP NOSIP KIAA1671 BSN SIPA1L2 SPEN | 7.46e-07 | 588 | 117 | 12 | 38580884 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF609 REXO4 NSD2 RPS3 NTPCR ZNF362 RBM28 NOSIP ZNF512B PRAM1 TJP1 MKI67 UQCRC2 SPEN RAD21 | 7.85e-07 | 954 | 117 | 15 | 36373674 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.95e-07 | 218 | 117 | 8 | 33378226 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | RPS3 PCLO INTS1 KLC2 NBEA EDC4 NOSIP SH3PXD2B TJP1 FARP1 DHX29 | 1.03e-06 | 498 | 117 | 11 | 36634849 |
| Pubmed | 1.31e-06 | 233 | 117 | 8 | 29518331 | ||
| Pubmed | 1.40e-06 | 103 | 117 | 6 | 21706016 | ||
| Pubmed | ANK2 MAP6 PCLO KLC2 NBEA EDC4 TJP1 FARP1 CASKIN1 DLG3 DLST UQCRC2 BSN SIPA1L2 DHX29 SDHA | 1.43e-06 | 1139 | 117 | 16 | 36417873 | |
| Pubmed | 1.83e-06 | 329 | 117 | 9 | 17474147 | ||
| Pubmed | ZNF609 NSD2 BMS1 FBRSL1 GMEB2 ZNF512B CASKIN1 CAPRIN2 ROBO2 BSN RAD21 | 1.85e-06 | 529 | 117 | 11 | 14621295 | |
| Pubmed | 2.05e-06 | 8 | 117 | 3 | 28438606 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.07e-06 | 430 | 117 | 10 | 35044719 | |
| Pubmed | 3.22e-06 | 263 | 117 | 8 | 34702444 | ||
| Pubmed | 4.38e-06 | 10 | 117 | 3 | 21780252 | ||
| Pubmed | ZNF609 NTPCR CC2D1A ZNF362 RBM28 EDC4 GMEB2 GSPT1 NOSIP PRAM1 KMT2D MKI67 SPEN DNM2 RAD21 | 4.63e-06 | 1103 | 117 | 15 | 34189442 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 4.77e-06 | 370 | 117 | 9 | 22922362 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | REXO4 RPAP3 RPS3 BMS1 RBM28 EDC4 MPRIP NOSIP KIAA1671 TJP1 MKI67 DLST UQCRC2 SPEN SDHA RAD21 | 5.03e-06 | 1257 | 117 | 16 | 36526897 |
| Pubmed | REXO4 TCOF1 RPS3 BMS1 RBM28 MPRIP ZNF512B TJP1 FARP1 MKI67 IRF2BPL DLST RAD21 | 5.83e-06 | 847 | 117 | 13 | 35850772 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | REXO4 TCOF1 NSD2 RPS3 PCLO BMS1 EDC4 GSPT1 MKI67 DLST UQCRC2 BSN SPEN DHX29 NNT SDHA RAD21 | 5.83e-06 | 1425 | 117 | 17 | 30948266 |
| Pubmed | ANK2 NSD2 PCLO SRCAP SLC4A3 PRX GSPT1 C4orf17 TJP1 CAPRIN2 DLG3 DLST UQCRC2 BSN SIPA1L2 SPAG17 SPEN | 6.82e-06 | 1442 | 117 | 17 | 35575683 | |
| Pubmed | 7.28e-06 | 390 | 117 | 9 | 17643375 | ||
| Pubmed | ANK2 TCOF1 RPAP3 BMS1 FRS2 CC2D1A RBM28 MPRIP ZNF512B PCGF6 FARP1 DLST UQCRC2 SIPA1L2 DHX29 SDHA RAD21 | 1.02e-05 | 1487 | 117 | 17 | 33957083 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 1.12e-05 | 2 | 117 | 2 | 23403927 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25313763 | ||
| Pubmed | TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. | 1.12e-05 | 2 | 117 | 2 | 12556483 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 1.12e-05 | 2 | 117 | 2 | 26793095 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20332206 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 1.12e-05 | 2 | 117 | 2 | 21935939 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15009703 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26538089 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 1.12e-05 | 2 | 117 | 2 | 25652077 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 35563063 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22745750 | ||
| Pubmed | Circular RNA WHSC1 exerts oncogenic properties by regulating miR-7/TAB2 in lung cancer. | 1.12e-05 | 2 | 117 | 2 | 34551195 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27321892 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 32493491 | ||
| Pubmed | 1.17e-05 | 87 | 117 | 5 | 12465718 | ||
| Pubmed | REXO4 TCOF1 RPS3 BMS1 FRS2 CC2D1A NBEA KIAA1671 TJP1 MKI67 DLG3 SPEN | 1.28e-05 | 777 | 117 | 12 | 35844135 | |
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 1.64e-05 | 15 | 117 | 3 | 30562487 | |
| Pubmed | 1.75e-05 | 332 | 117 | 8 | 25693804 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.12e-05 | 341 | 117 | 8 | 32971831 | |
| Pubmed | 2.29e-05 | 49 | 117 | 4 | 31762063 | ||
| Pubmed | 2.40e-05 | 347 | 117 | 8 | 17114649 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.61e-05 | 351 | 117 | 8 | 38297188 | |
| Pubmed | REPS1 ANK2 TCOF1 RPAP3 RPS3 FRS2 TAB2 CC2D1A PDLIM5 DHX29 SDHA | 2.83e-05 | 708 | 117 | 11 | 39231216 | |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 2.92e-05 | 18 | 117 | 3 | 25363768 | |
| Pubmed | 2.92e-05 | 18 | 117 | 3 | 27984743 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RPAP3 KLC2 PPP1R13B TAB2 CC2D1A RGS12 PDLIM5 KIAA1671 SH3PXD2B TJP1 FARP1 SIPA1L2 | 3.19e-05 | 853 | 117 | 12 | 28718761 |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 21334717 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 34724040 | ||
| Pubmed | CD147 expression in pituitary adenomas and its significance for clinical outcome. | 3.36e-05 | 3 | 117 | 2 | 20381119 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 28715234 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 15719068 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12511974 | ||
| Pubmed | UNC-51-like kinase regulation of fibroblast growth factor receptor substrate 2/3. | 3.36e-05 | 3 | 117 | 2 | 16887332 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 26074138 | ||
| Pubmed | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 3.36e-05 | 3 | 117 | 2 | 32573516 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 24174624 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12383797 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16967187 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 24273169 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 3.36e-05 | 3 | 117 | 2 | 28395327 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 3.36e-05 | 3 | 117 | 2 | 24046449 | |
| Pubmed | 3.51e-05 | 267 | 117 | 7 | 33417871 | ||
| Pubmed | 4.14e-05 | 608 | 117 | 10 | 16713569 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | REXO4 NSD2 INTS1 ZNF362 SRCAP ZNF512B PCGF6 MKI67 SPEN RAD21 | 4.14e-05 | 608 | 117 | 10 | 36089195 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TCOF1 RPS3 INTS1 RBM28 EDC4 SRCAP ZNF512B KIAA1671 TJP1 MKI67 UQCRC2 SPEN NNT | 4.25e-05 | 1024 | 117 | 13 | 24711643 |
| Pubmed | REXO4 REPS1 NSD2 NTPCR INTS1 BMS1 EDC4 MPRIP KIAA1671 FARP1 DLG3 UQCRC2 SPEN DHX29 SDHA RAD21 | 4.27e-05 | 1497 | 117 | 16 | 31527615 | |
| Pubmed | 4.71e-05 | 116 | 117 | 5 | 30652415 | ||
| Pubmed | 4.88e-05 | 497 | 117 | 9 | 23414517 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | REXO4 RPAP3 RPS3 BMS1 RBM28 SRCAP GSPT1 MPRIP PCGF6 RECQL4 UFD1 MKI67 DLST UQCRC2 DHX29 | 5.02e-05 | 1353 | 117 | 15 | 29467282 |
| Pubmed | REXO4 REPS1 ANK2 TCOF1 BMS1 CC2D1A RBM28 PDLIM5 MPRIP NOSIP TJP1 FARP1 MKI67 DLST UQCRC2 | 5.82e-05 | 1371 | 117 | 15 | 36244648 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 6.53e-05 | 202 | 117 | 6 | 33601422 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 35608281 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 6.70e-05 | 4 | 117 | 2 | 21689597 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 22846998 | ||
| Pubmed | SVIP is a novel VCP/p97-interacting protein whose expression causes cell vacuolation. | 6.70e-05 | 4 | 117 | 2 | 12529442 | |
| Pubmed | 7.13e-05 | 24 | 117 | 3 | 25348719 | ||
| Pubmed | Shp2 in myocytes is essential for cardiovascular and neointima development. | 7.13e-05 | 24 | 117 | 3 | 31634485 | |
| Pubmed | 7.80e-05 | 129 | 117 | 5 | 23563607 | ||
| Pubmed | CLUH regulates mitochondrial metabolism by controlling translation and decay of target mRNAs. | 8.08e-05 | 25 | 117 | 3 | 28188211 | |
| Pubmed | Angiopoietin-like 2 is essential to aortic valve development in mice. | 9.12e-05 | 26 | 117 | 3 | 36414704 | |
| Pubmed | 9.44e-05 | 216 | 117 | 6 | 31519766 | ||
| Pubmed | 1.00e-04 | 136 | 117 | 5 | 25429064 | ||
| Interaction | TOP3B interactions | COL4A5 REPS1 NSD2 NTPCR INTS1 FBRSL1 CC2D1A TBC1D25 EDC4 SRCAP TEP1 ZBTB42 MPRIP SH3PXD2B SLC38A10 KMT2D CASKIN1 ZNF398 DLST SIPA1L2 MBD5 SPEN ULK2 SDHA | 2.73e-06 | 1470 | 116 | 24 | int:TOP3B |
| Interaction | PFN1 interactions | ANK2 PCLO WIPF3 NBEA PDLIM5 MPRIP KIAA1671 TJP1 RECQL4 DLST SIPA1L2 SDHA DNM2 | 7.51e-06 | 509 | 116 | 13 | int:PFN1 |
| Interaction | CDH1 interactions | SPRR3 DDR2 FRS2 KLC2 PPP1R13B CC2D1A PDLIM5 GSPT1 MPRIP KIAA1671 NEDD9 SH3PXD2B PTPRD TJP1 MKI67 DHX29 | 8.40e-06 | 768 | 116 | 16 | int:CDH1 |
| Interaction | RGS14 interactions | 1.05e-05 | 240 | 116 | 9 | int:RGS14 | |
| Interaction | NHLH1 interactions | 1.18e-05 | 88 | 116 | 6 | int:NHLH1 | |
| Interaction | NAA40 interactions | REPS1 ANK2 TCOF1 RPAP3 KLC2 CC2D1A EDC4 SRCAP PDLIM5 MPRIP ZNF512B KIAA1671 TJP1 MKI67 SIPA1L2 DHX29 DNM2 RAD21 | 1.19e-05 | 978 | 116 | 18 | int:NAA40 |
| Interaction | KCTD13 interactions | ANK2 MAP6 RPS3 PCLO KLC2 NBEA EDC4 SIPA1 PDLIM5 MPRIP TJP1 FARP1 CASKIN1 DLG3 DLST UQCRC2 BSN SIPA1L2 DHX29 KNG1 SDHA DNM2 | 1.31e-05 | 1394 | 116 | 22 | int:KCTD13 |
| Interaction | TERF2IP interactions | ZNF609 NSD2 INTS1 ZNF362 GMEB2 SRCAP PRX ZNF512B TJP1 RECQL4 MKI67 SPEN RAD21 | 1.78e-05 | 552 | 116 | 13 | int:TERF2IP |
| Interaction | RNF123 interactions | ATRN REXO4 ZNF618 PCLO INTS1 BMS1 FRS2 NBEA RBM28 KIAA1671 SLC38A10 RECQL4 MMP2 PRG4 SDHA RAD21 | 2.00e-05 | 824 | 116 | 16 | int:RNF123 |
| Interaction | MEN1 interactions | ZNF609 REXO4 TCOF1 RPS3 INTS1 BMS1 RBM28 EDC4 SRCAP ZNF512B KMT2D TJP1 FARP1 MKI67 IRF2BPL DLST SPEN RAD21 | 2.35e-05 | 1029 | 116 | 18 | int:MEN1 |
| Interaction | SIRT7 interactions | REXO4 TCOF1 NSD2 INTS1 BMS1 RBM28 EDC4 TJP1 MKI67 UQCRC2 SPEN NNT SDHA DNM2 RAD21 | 2.42e-05 | 744 | 116 | 15 | int:SIRT7 |
| Interaction | H1-4 interactions | REXO4 TCOF1 NSD2 RPS3 BMS1 RBM28 EDC4 PDLIM5 PRX ZNF512B PRAM1 RECQL4 BSN SPAG17 | 2.48e-05 | 656 | 116 | 14 | int:H1-4 |
| Interaction | LHX1 interactions | 2.90e-05 | 103 | 116 | 6 | int:LHX1 | |
| Interaction | FTL interactions | BMS1 CC2D1A SRCAP TEP1 PCGF6 SH3PXD2B RECQL4 DHX29 KNG1 RAD21 | 3.34e-05 | 348 | 116 | 10 | int:FTL |
| Interaction | CRK interactions | 5.60e-05 | 370 | 116 | 10 | int:CRK | |
| Interaction | BAG2 interactions | ZNF609 KLC2 PPP1R13B TAB2 EDC4 TEP1 PDLIM5 KIAA1671 TRIM66 RECQL4 IRF2BPL DLST SPEN | 6.09e-05 | 622 | 116 | 13 | int:BAG2 |
| Interaction | FMR1 interactions | TCOF1 RPS3 APC2 NBEA EDC4 ZBTB42 NOSIP TJP1 CASKIN1 MKI67 DLST BSN | 6.19e-05 | 536 | 116 | 12 | int:FMR1 |
| Interaction | CTNNB1 interactions | ANK2 NSD2 RPS3 APC2 DDR2 KLC2 PPP1R13B PDLIM5 MPRIP KIAA1671 RNF14 KMT2D TJP1 MKI67 IRF2BPL SIPA1L2 NNT | 6.47e-05 | 1009 | 116 | 17 | int:CTNNB1 |
| Interaction | FGFR1 interactions | REPS1 ANK2 NTPCR FRS2 PPP1R13B CC2D1A NBEA SH3PXD2B FARP1 DNM3 MMP2 NRSN1 DNM2 | 7.15e-05 | 632 | 116 | 13 | int:FGFR1 |
| Interaction | SYNGAP1 interactions | 7.20e-05 | 307 | 116 | 9 | int:SYNGAP1 | |
| Interaction | DNMBP interactions | 8.21e-05 | 124 | 116 | 6 | int:DNMBP | |
| Interaction | LHX2 interactions | 9.20e-05 | 183 | 116 | 7 | int:LHX2 | |
| Interaction | RPL30 interactions | REXO4 NSD2 RPS3 BMS1 RBM28 GSPT1 RECQL4 DLST DHX29 SDHA RAD21 | 9.26e-05 | 474 | 116 | 11 | int:RPL30 |
| Interaction | ZNF767P interactions | 9.85e-05 | 16 | 116 | 3 | int:ZNF767P | |
| Interaction | PIPSL interactions | 1.06e-04 | 252 | 116 | 8 | int:PIPSL | |
| Interaction | ENTR1 interactions | 1.09e-04 | 188 | 116 | 7 | int:ENTR1 | |
| Interaction | POLR1G interactions | REXO4 TCOF1 RPAP3 NSD2 BMS1 ZNF362 RBM28 SRCAP ZNF512B POLR3D RAD21 | 1.22e-04 | 489 | 116 | 11 | int:POLR1G |
| Interaction | MECP2 interactions | REXO4 TCOF1 MAP6 NSD2 RPS3 ZNF618 INTS1 BMS1 RBM28 SRCAP ZNF512B TJP1 FARP1 MKI67 DNM3 DLST UQCRC2 SIPA1L2 SPEN | 1.34e-04 | 1287 | 116 | 19 | int:MECP2 |
| Interaction | KCNA3 interactions | REPS1 ANK2 TCOF1 RPAP3 RPS3 FRS2 TAB2 CC2D1A PDLIM5 MPRIP CAPRIN2 BSN SPEN DHX29 SDHA | 1.43e-04 | 871 | 116 | 15 | int:KCNA3 |
| Interaction | RPS6 interactions | REXO4 NSD2 RPS3 PCLO BMS1 FRS2 PPP1R13B RBM28 GSPT1 ZNF512B RECQL4 MKI67 DHX29 SDHA RAD21 | 1.48e-04 | 874 | 116 | 15 | int:RPS6 |
| Interaction | DPPA4 interactions | 1.60e-04 | 140 | 116 | 6 | int:DPPA4 | |
| Interaction | CEP104 interactions | 1.64e-04 | 89 | 116 | 5 | int:CEP104 | |
| Interaction | WWTR1 interactions | RPAP3 PPP1R13B EDC4 SRCAP PDLIM5 MPRIP KIAA1671 SH3PXD2B KMT2D TJP1 | 1.65e-04 | 422 | 116 | 10 | int:WWTR1 |
| Interaction | LZTS2 interactions | BMS1 FBRSL1 PPP1R13B SIPA1 ZNF512B KIAA1671 TRIM66 TJP1 RECQL4 SIPA1L2 RHNO1 | 1.82e-04 | 512 | 116 | 11 | int:LZTS2 |
| Interaction | MYCBP2 interactions | 2.15e-04 | 355 | 116 | 9 | int:MYCBP2 | |
| Interaction | NUP43 interactions | ZNF609 REXO4 NSD2 BMS1 KLC2 CCDC168 RBM28 SRCAP KMT2D RECQL4 MKI67 SPEN | 2.60e-04 | 625 | 116 | 12 | int:NUP43 |
| Interaction | PCGF5 interactions | 2.96e-04 | 101 | 116 | 5 | int:PCGF5 | |
| Interaction | RPGRIP1L interactions | 3.28e-04 | 225 | 116 | 7 | int:RPGRIP1L | |
| Interaction | PARD3 interactions | 3.32e-04 | 298 | 116 | 8 | int:PARD3 | |
| Interaction | RHOB interactions | LPCAT1 DDR2 BMS1 FRS2 CC2D1A NBEA RBM28 MPRIP TJP1 FARP1 ROBO2 DLG3 UQCRC2 SIPA1L2 | 3.36e-04 | 840 | 116 | 14 | int:RHOB |
| Interaction | ZNF76 interactions | 3.38e-04 | 104 | 116 | 5 | int:ZNF76 | |
| Interaction | NFIX interactions | 3.46e-04 | 227 | 116 | 7 | int:NFIX | |
| Interaction | DYRK1A interactions | ATRN TCOF1 NTPCR PDLIM5 MPRIP TRIM66 SLC38A10 KMT2D MKI67 DNM3 SIPA1L2 | 3.46e-04 | 552 | 116 | 11 | int:DYRK1A |
| Interaction | COIL interactions | NSD2 RPS3 BMS1 KLC2 ZNF362 RBM28 PDLIM5 ZNF512B MKI67 UQCRC2 RAD21 | 3.46e-04 | 552 | 116 | 11 | int:COIL |
| Interaction | CBX3 interactions | REXO4 TCOF1 NSD2 ZNF362 PDLIM5 NOSIP ZNF512B TRIM66 PCGF6 RECQL4 MKI67 SPEN | 3.50e-04 | 646 | 116 | 12 | int:CBX3 |
| GeneFamily | PDZ domain containing | 2.41e-07 | 152 | 76 | 8 | 1220 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.77e-03 | 15 | 76 | 2 | 26 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF609 ZNF618 KLF15 ZBTB12 ZNF362 ZBTB42 ZNF783 ZNF398 ZNF282 | 3.09e-03 | 718 | 76 | 9 | 28 |
| GeneFamily | PWWP domain containing | 3.81e-03 | 22 | 76 | 2 | 1147 | |
| GeneFamily | Fibronectin type III domain containing | 4.62e-03 | 160 | 76 | 4 | 555 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.31e-03 | 26 | 76 | 2 | 904 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-08 | 195 | 117 | 8 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-08 | 195 | 117 | 8 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 5.74e-08 | 199 | 117 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 5.74e-08 | 199 | 117 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.66e-07 | 164 | 117 | 7 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.23e-07 | 186 | 117 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.85e-07 | 196 | 117 | 7 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.16e-07 | 197 | 117 | 7 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.16e-07 | 197 | 117 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-07 | 198 | 117 | 7 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 9.80e-07 | 199 | 117 | 7 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 9.80e-07 | 199 | 117 | 7 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 200 | 117 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 200 | 117 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 200 | 117 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.01e-06 | 200 | 117 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.01e-06 | 200 | 117 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Kidney-Fibroblasts|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.01e-06 | 200 | 117 | 7 | 2c265ad8314a21bce50ac21b16da2fea125366ea | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.95e-06 | 175 | 117 | 6 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.95e-06 | 175 | 117 | 6 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.95e-06 | 175 | 117 | 6 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 176 | 117 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 176 | 117 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.43e-06 | 181 | 117 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.97e-06 | 183 | 117 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.97e-06 | 183 | 117 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 9.26e-06 | 184 | 117 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-06 | 185 | 117 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-06 | 185 | 117 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 187 | 117 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.05e-05 | 188 | 117 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 188 | 117 | 6 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 188 | 117 | 6 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-05 | 190 | 117 | 6 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-05 | 190 | 117 | 6 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-05 | 190 | 117 | 6 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 191 | 117 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 191 | 117 | 6 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 191 | 117 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 191 | 117 | 6 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 191 | 117 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 191 | 117 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 192 | 117 | 6 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 193 | 117 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.21e-05 | 193 | 117 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 194 | 117 | 6 | 20a0439fa02c5f8107612e34c7ab54120b9b8573 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 195 | 117 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 195 | 117 | 6 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 196 | 117 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 196 | 117 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 196 | 117 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 196 | 117 | 6 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 196 | 117 | 6 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 196 | 117 | 6 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 196 | 117 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 197 | 117 | 6 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-05 | 197 | 117 | 6 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.40e-05 | 198 | 117 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 198 | 117 | 6 | b58138581f1a9073267d64c1211c5b9b4de71d3e | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 198 | 117 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.44e-05 | 199 | 117 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 199 | 117 | 6 | b4824d3683a4e3025b8e74a0f1755b331b2a0ba7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 117 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 199 | 117 | 6 | ce8dbfd969b3b9c08e1c57c2bfd899818e878731 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 117 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 199 | 117 | 6 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 199 | 117 | 6 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.44e-05 | 199 | 117 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-05 | 200 | 117 | 6 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.49e-05 | 200 | 117 | 6 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-05 | 200 | 117 | 6 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-05 | 200 | 117 | 6 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 1.49e-05 | 200 | 117 | 6 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 1.49e-05 | 200 | 117 | 6 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.44e-05 | 140 | 117 | 5 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| ToppCell | 368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-05 | 150 | 117 | 5 | 17b3ac5ddc47b9cba0a27b268d63a6e491b2b111 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.93e-05 | 151 | 117 | 5 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 159 | 117 | 5 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 159 | 117 | 5 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 159 | 117 | 5 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 161 | 117 | 5 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 7.09e-05 | 163 | 117 | 5 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 164 | 117 | 5 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 164 | 117 | 5 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 168 | 117 | 5 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| Disease | abdominal aortic aneurysm (implicated_via_orthology) | 4.64e-06 | 9 | 114 | 3 | DOID:7693 (implicated_via_orthology) | |
| Disease | prostate carcinoma | GDF5 PRTG ANK2 FBRSL1 PPP1R13B GMEB2 ZBTB42 PDLIM5 NOSIP NEDD9 SH3PXD2B PTPRD BSN SPEN | 9.03e-06 | 891 | 114 | 14 | EFO_0001663 |
| Disease | collagen disease (implicated_via_orthology) | 1.20e-05 | 12 | 114 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | roundabout homolog 2 measurement | 4.43e-05 | 3 | 114 | 2 | EFO_0020713 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 1.47e-04 | 5 | 114 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 1.47e-04 | 5 | 114 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 1.47e-04 | 5 | 114 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 2.82e-04 | 33 | 114 | 3 | EFO_0007905 | |
| Disease | Paraganglioma | 3.07e-04 | 7 | 114 | 2 | cv:C0030421 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 3.07e-04 | 7 | 114 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | paraganglioma (is_implicated_in) | 3.07e-04 | 7 | 114 | 2 | DOID:0050773 (is_implicated_in) | |
| Disease | Abnormality of the skeletal system | 4.08e-04 | 8 | 114 | 2 | C4021790 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.16e-04 | 169 | 114 | 5 | DOID:3908 (is_marker_for) | |
| Disease | pseudoxanthoma elasticum (is_implicated_in) | 5.23e-04 | 9 | 114 | 2 | DOID:2738 (is_implicated_in) | |
| Disease | mean platelet volume | AFF3 FBRSL1 SRCAP RGS12 PDLIM5 MPRIP ZNF512B STAC2 DNM3 DLG3 NNT ULK2 | 5.93e-04 | 1020 | 114 | 12 | EFO_0004584 |
| Disease | myopathy (implicated_via_orthology) | 8.56e-04 | 48 | 114 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Centriacinar Emphysema | 9.52e-04 | 12 | 114 | 2 | C0221227 | |
| Disease | Panacinar Emphysema | 9.52e-04 | 12 | 114 | 2 | C0264393 | |
| Disease | Focal Emphysema | 9.52e-04 | 12 | 114 | 2 | C2350878 | |
| Disease | intracranial aneurysm (is_implicated_in) | 9.52e-04 | 12 | 114 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | mammographic density measurement | 9.64e-04 | 50 | 114 | 3 | EFO_0005941 | |
| Disease | alcohol consumption measurement | ZNF618 PCLO DDR2 AFF3 FBRSL1 PPP1R13B NBEA TCAP RGS12 NOSIP C4orf17 TRIM66 FARP1 | 1.03e-03 | 1242 | 114 | 13 | EFO_0007878 |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.12e-03 | 13 | 114 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.64e-03 | 702 | 114 | 9 | C0009402 | |
| Disease | Schizoaffective disorder-bipolar type | 1.71e-03 | 16 | 114 | 2 | EFO_0009965 | |
| Disease | temporal arteritis (is_implicated_in) | 1.71e-03 | 16 | 114 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | total blood protein measurement | 1.84e-03 | 449 | 114 | 7 | EFO_0004536 | |
| Disease | Muscle hypotonia | 1.94e-03 | 17 | 114 | 2 | C0026827 | |
| Disease | Pulmonary Emphysema | 1.94e-03 | 17 | 114 | 2 | C0034067 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.11e-03 | 139 | 114 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | syndrome (implicated_via_orthology) | 2.17e-03 | 18 | 114 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | stomach cancer (is_marker_for) | 2.28e-03 | 142 | 114 | 4 | DOID:10534 (is_marker_for) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.65e-03 | 71 | 114 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | physical activity measurement | 2.67e-03 | 245 | 114 | 5 | EFO_0008002 | |
| Disease | Fetal Growth Retardation | 2.69e-03 | 20 | 114 | 2 | C0015934 | |
| Disease | waist-hip ratio | GDF5 DTX1 AFF3 SIPA1 MPRIP NOSIP NEDD9 TRIM66 SH3PXD2B PTPRD CAPRIN2 DNM3 | 2.81e-03 | 1226 | 114 | 12 | EFO_0004343 |
| Disease | pulse pressure measurement | ANK2 ZNF618 FBRSL1 NBEA SIPA1 SRCAP PDLIM5 TRIM66 FNDC1 PTPRD ELN MBD5 NNT | 2.82e-03 | 1392 | 114 | 13 | EFO_0005763 |
| Disease | albumin:globulin ratio measurement | 2.87e-03 | 73 | 114 | 3 | EFO_0005128 | |
| Disease | parental longevity | 3.12e-03 | 494 | 114 | 7 | EFO_0007796 | |
| Disease | Liver Cirrhosis, Experimental | 3.15e-03 | 774 | 114 | 9 | C0023893 | |
| Disease | Craniofacial Abnormalities | 3.20e-03 | 156 | 114 | 4 | C0376634 | |
| Disease | atrial fibrillation | 3.24e-03 | 371 | 114 | 6 | EFO_0000275 | |
| Disease | Disproportionate short stature | 3.34e-03 | 77 | 114 | 3 | C0878659 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.55e-03 | 23 | 114 | 2 | C1708353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPKVVQSVKVTPGPP | 506 | Q68DN1 | |
| HLVGVPKPGVPQTPV | 91 | P51826 | |
| PKPGVPQTPVNKIDE | 96 | P51826 | |
| GPPPGSRANPLVKKE | 276 | Q9HCM7 | |
| EPVEPPHSGTPQKAK | 151 | P48751 | |
| PKHKVSEQRPGTPGP | 171 | O75638 | |
| AKGPVFSVPVGEIKP | 196 | Q14511 | |
| LPKSPNPSFEKVPVG | 391 | Q7Z478 | |
| PPIVVVVMGPPKVGK | 81 | Q14692 | |
| PTEKPGIEIGKVPPP | 436 | Q96KQ4 | |
| PGVPVPQLTSVPLGK | 386 | Q9UKD1 | |
| PSPIIKFPGDVAPKT | 31 | P08253 | |
| GPTPTLGPVTPEICK | 456 | P08253 | |
| SKPATGEPQKGQPEP | 601 | Q9NW13 | |
| KVKATAAPAGAPPQP | 21 | P22695 | |
| SPTQEPLPGGKTPFK | 266 | Q96QF0 | |
| PPPQGVKRKAGQIDP | 471 | O60216 | |
| PAPADKLTPKGPGQV | 686 | Q6P2E9 | |
| DVQPGPSVGPPSKDK | 141 | Q9Y314 | |
| LPVSPSGKTEKQPPV | 1961 | Q01484 | |
| GPAPATAKVKPTPQL | 796 | Q8WXD9 | |
| TSKKVPLPGPGSPEV | 1246 | Q8WXD9 | |
| KPGAFIPGAPVQPVV | 221 | Q8NF37 | |
| TKGRAGLVTPPPKNP | 626 | Q460N3 | |
| KVEPPTPQEPGPAKV | 161 | Q6WCQ1 | |
| TVTPKGQLPGGKAPP | 121 | P43026 | |
| PLKKQGSVVPGPPKD | 481 | Q96JE9 | |
| APVKDQGPIVPAPVK | 601 | Q96JE9 | |
| AATVGKVPPTPPEKT | 261 | Q9BY89 | |
| GSSPTPEPPQKEVQK | 66 | Q969S2 | |
| APKPKSSPEQPIGQG | 1321 | Q8N201 | |
| VVKPVQPSGPEGVPH | 506 | Q16832 | |
| PPDLIGGSIKTVPKP | 1341 | O75882 | |
| EPPPSKPTVAKTGLA | 176 | Q96MC5 | |
| TPVVKAVPEAPKGGE | 646 | Q9UPA5 | |
| DLPGITKVPVGDQPP | 136 | Q9UQ16 | |
| KKRSVLGPVSTGPPP | 156 | A6NNH2 | |
| GPPPPVGVKTVALSA | 71 | Q9H1B7 | |
| PGTVKPPVQPPGTTK | 346 | Q9Y6V0 | |
| PGPKALAQPPGVGKT | 386 | Q9Y6V0 | |
| PTKTPVQQPGPGKIP | 436 | Q9Y6V0 | |
| PSGPTKPSEGPAKVE | 296 | P29536 | |
| PPNTTPIKNGSPEIK | 111 | O96028 | |
| QPVTKAPGPGETKIP | 166 | Q8IZ57 | |
| PGTIILGTIPVPKGK | 136 | Q9BSD7 | |
| PDPVGTPTIFKPQSK | 2226 | P46013 | |
| AAPKPEPVPVQKGEP | 86 | Q96HC4 | |
| DLPGITKVPVGDQPP | 136 | P50570 | |
| PPVSKSDVKPVPGVP | 361 | Q86Y01 | |
| EIPKPKSVVAPPGAP | 56 | P15170 | |
| VKKLQGGTPQEPPNP | 561 | Q9H0B6 | |
| PEAPAGPPVGVKVTL | 816 | Q2VWP7 | |
| GKPVSAVKPTVAPPL | 196 | P36957 | |
| PEKPRGTQKTTPGVP | 1771 | O95996 | |
| ERGQKPPPTPSGKLV | 26 | Q9Y4F1 | |
| PEGVKFVLGPTPVQK | 246 | Q8WU20 | |
| PIKGPGPFNETVTEK | 141 | Q4ZHG4 | |
| AETGKPPTVKSPPTV | 241 | Q53FE4 | |
| PKGDPGQTITQPGKP | 651 | P29400 | |
| IVKKPEPHQPGPGST | 531 | P57058 | |
| PVPAAVPTQVAGPKG | 811 | Q6P1N0 | |
| VPTQVAGPKGKAPPV | 816 | Q6P1N0 | |
| DVGPVPPKPVPGKST | 81 | Q92796 | |
| PRSTAPGGIPNPEKK | 66 | Q8WXS3 | |
| EPKDVPKPVHQPVGS | 591 | Q6IMN6 | |
| PVGPQATSSGIKVPP | 476 | Q9P267 | |
| IAPVPIAAKPVGSGP | 281 | Q9UIH9 | |
| KTEGPTPIPSLAKPG | 541 | P01042 | |
| KAFPGTVPIPPQVKS | 6311 | Q8NDH2 | |
| LPGVPTGAGVKPKAP | 166 | P15502 | |
| GTVKELPKGPEQVPV | 846 | Q9HBR0 | |
| VPKPAVPQPVPSSKG | 221 | Q9BYE7 | |
| QITVKALPKPPGTPV | 316 | P23468 | |
| APIGKGKPVSVPLKP | 166 | Q8IWW8 | |
| DGKVIFPAPTPKNIP | 431 | Q13423 | |
| SKKPASGPGAVVRPP | 46 | Q9GZR2 | |
| TGTPNSPEPGPVLVK | 186 | Q9BSD3 | |
| PGQPPTQDIKPIKTE | 276 | P05423 | |
| PPPPGRGQVKKGSVS | 131 | Q96D71 | |
| EVGSPKDPGKSLPPV | 586 | Q3MII6 | |
| GFVGPVPPKPKDQRS | 636 | Q9NYJ8 | |
| RPGDKVPPIKPNAGE | 476 | P31040 | |
| PVLPGKTGPTVTQVK | 741 | Q13428 | |
| KPPGTGPVPSFAEKV | 141 | O94761 | |
| VVVPVKKPPPGSLAV | 1791 | Q8NFP9 | |
| EAPSKPGLPKPQATV | 146 | Q9NPR9 | |
| PQVGGLPKKSVPQPE | 231 | Q96QH2 | |
| GPPIPKGVTFPKSAV | 761 | Q9P2F8 | |
| QPIPESGDPKGTPKS | 951 | Q96FS4 | |
| PTPGKPILPVQTGEQ | 36 | Q9Y2E8 | |
| TPISEQKGGKPEPPA | 221 | P23396 | |
| ITKQLPPVVPVSKPG | 136 | O15273 | |
| IKTPLVSPPGPLTKG | 196 | A6NGB9 | |
| PTPGPTTLGPKKEIT | 571 | Q6ZRS2 | |
| KIEKQIATSGPPPEG | 56 | Q8NHG7 | |
| KPTPKPPVVDEAGSG | 211 | Q92954 | |
| TFPSVEKKTPGPPFG | 1721 | Q6Q759 | |
| PQPGNTKIPEPGCTK | 46 | Q9UBC9 | |
| TKIPEPGCTKVPEPG | 51 | Q9UBC9 | |
| TKVPEPGCTKVPEPG | 91 | Q9UBC9 | |
| QKQEPPASVGPKPTL | 166 | Q15735 | |
| PEPKCPSVATPGQVK | 266 | Q9UBS8 | |
| VPPSTVAPPQGVVKA | 251 | Q9Y330 | |
| EPPEPFQKIGPKTGN | 241 | Q5T7W0 | |
| GLGPVPGEPAKPKTS | 1426 | O14924 | |
| KIFKIPPPPGKTGVQ | 861 | Q99973 | |
| VVKVPPASKAPQQPG | 3216 | Q96T58 | |
| QPPLPGAKPGVSERK | 196 | A6NJB7 | |
| VVKPIDNPPHPGSTK | 416 | Q9H6T3 | |
| AGQLVEPSTAPPKPK | 26 | Q8NEW7 | |
| TEQLRGPTPKPPGVI | 546 | A1X283 | |
| PGPEEKSPGQQLPKA | 271 | Q6ZMT1 | |
| GPEVKVPKGPEVKLP | 431 | Q9BXM0 | |
| PPGIKGDIPKVPVAF | 131 | Q8TD17 | |
| NIKFVTPVPGPQGKE | 71 | O15014 | |
| LPGPPSKPQVTDVTK | 521 | Q9HCK4 | |
| KQKPMGSPVSGVPEP | 316 | Q6UWB4 | |
| PKPPPVPAAKGLVVG | 246 | B2RXF5 | |
| VASKPSGAPIIGPKP | 1296 | Q07157 | |
| LEQGPVKKSCPVPVP | 271 | Q8IYT8 | |
| PIGVSKPVTIGKPVG | 191 | Q96KM6 | |
| GVEPSPSPIKPGDIK | 241 | Q92890 | |
| KIKAENPGGPPVLVV | 196 | Q5T0B9 | |
| TPGAKKGPPAPIENE | 956 | O15016 | |
| PPGSKGEAPKVPVTF | 186 | Q9UDV7 | |
| PPGSKGEAPKVPVTF | 131 | Q6ZMS7 | |
| VKASPVPSDPEKPGT | 1851 | O14686 |